Sg3 Management, LLC Exelixis, Inc. Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $407,500 - $485,250	-25,000 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$15.68 - $22.27 $392,000 - $556,750	25,000 New	25,000 $392,000
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $392,000 - $556,750	25,000 New	25,000 $392,000
Q1 2017 Jan 25, 2018	SELL	N/A	-10,000 Closed	0 $0
Q4 2016 Jan 24, 2018	BUY	N/A	10,000	10,000 $149,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.